CD274 and neoplasm: Coadministration of immune checkpoint inhibitors, anti-PD-1 or anti-PD-L1, enhanced the antitumor effect of CDDP plus CBP501 and there was tumor eradication confirmed in about 17% of mice bearing CT26WT tumor (Figures 3-4).